140 related articles for article (PubMed ID: 7499866)
1. Characterization of mutant forms of recombinant human properdin lacking single thrombospondin type I repeats. Identification of modules important for function.
Higgins JM; Wiedemann H; Timpl R; Reid KB
J Immunol; 1995 Dec; 155(12):5777-85. PubMed ID: 7499866
[TBL] [Abstract][Full Text] [Related]
2. Expression and characterisation of the thrombospondin type I repeats of human properdin.
Perdikoulis MV; Kishore U; Reid KB
Biochim Biophys Acta; 2001 Aug; 1548(2):265-77. PubMed ID: 11513971
[TBL] [Abstract][Full Text] [Related]
3. Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.
van den Bos RM; Pearce NM; Granneman J; Brondijk THC; Gros P
Front Immunol; 2019; 10():2097. PubMed ID: 31552043
[TBL] [Abstract][Full Text] [Related]
4. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
[TBL] [Abstract][Full Text] [Related]
5. A recombinant two-module form of human properdin is an inhibitor of the complement alternative pathway.
Kouser L; Abdul-Aziz M; Tsolaki AG; Singhal D; Schwaeble WJ; Urban BC; Khan HA; Sim RB; Kishore U
Mol Immunol; 2016 May; 73():76-87. PubMed ID: 27060503
[TBL] [Abstract][Full Text] [Related]
6. Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs.
Goundis D; Reid KB
Nature; 1988 Sep; 335(6185):82-5. PubMed ID: 3045564
[TBL] [Abstract][Full Text] [Related]
7. Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat.
Smith KF; Nolan KF; Reid KB; Perkins SJ
Biochemistry; 1991 Aug; 30(32):8000-8. PubMed ID: 1868073
[TBL] [Abstract][Full Text] [Related]
8. Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System.
Pedersen DV; Gadeberg TAF; Thomas C; Wang Y; Joram N; Jensen RK; Mazarakis SMM; Revel M; El Sissy C; Petersen SV; Lindorff-Larsen K; Thiel S; Laursen NS; Fremeaux-Bacchi V; Andersen GR
Front Immunol; 2019; 10():2007. PubMed ID: 31507604
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the function of activated properdin by squid chondroitin sulfate E glycosaminoglycan and murine bone marrow-derived mast cell chondroitin sulfate E proteoglycan.
Wilson JG; Fearon DT; Stevens RL; Seno N; Austen KF
J Immunol; 1984 Jun; 132(6):3058-63. PubMed ID: 6427331
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
[TBL] [Abstract][Full Text] [Related]
11. Properdin binds to sulfatide [Gal(3-SO4)beta 1-1 Cer] and has a sequence homology with other proteins that bind sulfated glycoconjugates.
Holt GD; Pangburn MK; Ginsburg V
J Biol Chem; 1990 Feb; 265(5):2852-5. PubMed ID: 2303431
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning of the cDNA coding for properdin, a positive regulator of the alternative pathway of human complement.
Nolan KF; Schwaeble W; Kaluz S; Dierich MP; Reid KB
Eur J Immunol; 1991 Mar; 21(3):771-6. PubMed ID: 2009915
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
14. The dimeric and trimeric solution structures of the multidomain complement protein properdin by X-ray scattering, analytical ultracentrifugation and constrained modelling.
Sun Z; Reid KB; Perkins SJ
J Mol Biol; 2004 Nov; 343(5):1327-43. PubMed ID: 15491616
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of properdin deficiency type III: dysfunction produced by a single point mutation in exon 9 of the structural gene causing a tyrosine to aspartic acid interchange.
Fredrikson GN; Westberg J; Kuijper EJ; Tijssen CC; Sjöholm AG; Uhlén M; Truedsson L
J Immunol; 1996 Oct; 157(8):3666-71. PubMed ID: 8871668
[TBL] [Abstract][Full Text] [Related]
16. Expression and functional analysis of properdin in zebrafish Danio rerio.
Zhang Y; Chen J; Yao F; Ji D; Li H; Zhang S
Dev Comp Immunol; 2013 Jun; 40(2):123-31. PubMed ID: 23416932
[TBL] [Abstract][Full Text] [Related]
17. Three isoforms of complement properdin factor P in trout: cloning, expression, gene organization and constrained modeling.
Chondrou M; Papanastasiou AD; Spyroulias GA; Zarkadis IK
Dev Comp Immunol; 2008; 32(12):1454-66. PubMed ID: 18638502
[TBL] [Abstract][Full Text] [Related]
18. The properdin-like type I repeats of human thrombospondin contain a cell attachment site.
Prater CA; Plotkin J; Jaye D; Frazier WA
J Cell Biol; 1991 Mar; 112(5):1031-40. PubMed ID: 1999454
[TBL] [Abstract][Full Text] [Related]
19. Chimeric and truncated forms of human complement protein C8 alpha reveal binding sites for C8 beta and C8 gamma within the membrane attack complex/perforin region.
Plumb ME; Scibek JJ; Barber TD; Dunlap RJ; Platteborze PL; Sodetz JM
Biochemistry; 1999 Jun; 38(26):8478-84. PubMed ID: 10387094
[TBL] [Abstract][Full Text] [Related]
20. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
Hinshelwood J; Spencer DI; Edwards YJ; Perkins SJ
J Mol Biol; 1999 Nov; 294(2):587-99. PubMed ID: 10610782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
